---
title: "CJC-1295 | PepTracker Pro"
description: "A growth hormone releasing hormone analog studied for stimulating growth hormone secretion."
lang: en
json-ld: |
  [
    {
      "@context": "https://schema.org",
      "@type": "Organization",
      "name": "PepTracker Pro",
      "url": "https://peptrackerpro.com",
      "logo": "https://peptrackerpro.com/favicon.png",
      "description": "Evidence-based educational resource dedicated to improving peptide research literacy.",
      "contactPoint": {
        "@type": "ContactPoint",
        "email": "hello@peptrackerpro.com",
        "contactType": "customer support"
      },
      "sameAs": []
    },
    {
      "@context": "https://schema.org",
      "@type": "MedicalWebPage",
      "name": "CJC-1295",
      "description": "A growth hormone releasing hormone analog studied for stimulating growth hormone secretion.",
      "url": "https://peptrackerpro.com/peptides/cjc-1295",
      "lastReviewed": "2026-05-27",
      "reviewedBy": {
        "@type": "Organization",
        "name": "PepTracker Pro Research Team",
        "url": "https://peptrackerpro.com"
      },
      "isPartOf": {
        "@type": "WebSite",
        "name": "PepTracker Pro",
        "url": "https://peptrackerpro.com"
      }
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://peptrackerpro.com"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Peptides",
          "item": "https://peptrackerpro.com/peptides"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "CJC-1295",
          "item": "https://peptrackerpro.com/peptides/cjc-1295"
        }
      ]
    },
    {
      "@context": "https://schema.org",
      "@type": "FAQPage",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "People researching growth hormone secretagogues?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "CJC-1295 is a research peptide studied in preclinical models. A growth hormone releasing hormone analog studied for stimulating growth hormone secretion."
          }
        },
        {
          "@type": "Question",
          "name": "Those interested in body composition research?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "CJC-1295 is a research peptide studied in preclinical models. A growth hormone releasing hormone analog studied for stimulating growth hormone secretion."
          }
        },
        {
          "@type": "Question",
          "name": "Individuals exploring sleep optimization?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "CJC-1295 is a research peptide studied in preclinical models. A growth hormone releasing hormone analog studied for stimulating growth hormone secretion."
          }
        }
      ]
    }
  ]
---

[Skip to main content](#main)

**Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) 

[PepTracker Pro](/)

[Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start)

[Open the App](https://app.peptrackerpro.com)

[Peptides](/peptides)/ CJC-1295 

**Research-only content.** This page is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer)

# CJC-1295

Medium Evidence 

A growth hormone releasing hormone analog studied for stimulating growth hormone secretion.

Aliases CJC-1295 DAC +2 more 

Evidence Medium Evidence 

Last Updated  2026-05-27 

Reading Time  2 min 

## Table of Contents

1.  [What It Is](#what-it-is)
2.  [Regulatory Status](#regulatory-status)
3.  [Why Researchers Study It](#why-researchers-study)
4.  [Proposed Mechanisms](#proposed-mechanisms)
5.  [Evidence Snapshot](#evidence-snapshot)
6.  [Commonly Discussed Benefits](#benefits)
7.  [Safety & Cautions](#safety)
8.  [Comparisons](#comparisons)
9.  [Calculator Tools](#calculator)
10.  [Citations](#citations)

## What It Is

CJC-1295 (without DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of 29 amino acids with modified residues to improve stability and receptor binding. It stimulates the anterior pituitary to release growth hormone in a pulsatile pattern that more closely mimics natural physiology than exogenous GH administration. CJC-1295 is most commonly studied in combination with ipamorelin, where the two peptides synergistically amplify GH pulse amplitude — CJC-1295 extending the duration of the GH pulse while ipamorelin increases its peak. Clinical studies have shown that CJC-1295 increases mean plasma GH concentrations 2- to 10-fold for up to six days following a single injection, with corresponding increases in IGF-1 levels persisting for 9–11 days. The no-DAC formulation has a shorter half-life than the DAC version, which researchers often prefer for more physiological GH pulsatility rather than sustained elevation. CJC-1295 was affected by the FDA's October 2023 Category 2 designation for compounding. As of April 2026, the Category 2 nomination has been withdrawn for 503A compounding pharmacies, restoring limited compounding eligibility. It is expected to be reviewed by the PCAC before February 2027. CJC-1295 is not FDA-approved for any indication.

Also known as:  CJC-1295 DAC, Modified GRF 1-29, Mod GRF 

## Regulatory Status

Category 1 — Bulk Compounding 

Returned to Category 1 compounding eligibility under HHS February 27, 2026 reclassification. Legal for compounding pharmacies with a prescription.

Effective: February 2026

[View FDA Source](https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding)

## Why Researchers Study It

CJC-1295 is of particular interest because it provides sustained growth hormone elevation through a modified GHRH structure. Its DAC variant extends the half-life to approximately one week, enabling less frequent dosing in research protocols compared to native GHRH.

## Proposed Mechanisms

-   Binds to GHRH receptors on anterior pituitary somatotrophs
-   Drug Affinity Complex (DAC) binds albumin, extending half-life to ~6–8 days
-   Stimulates pulsatile GH release, preserving natural secretion patterns
-   Increases IGF-1 levels downstream of GH elevation
-   Does not significantly suppress endogenous GHRH production at studied doses

## Evidence Snapshot

Medium Evidence 

Low 

Medium 

High 

Study Type

Model

Outcome

Link

Human (Phase I/II)

Healthy adults (n=56)

2–10 fold increase in GH levels sustained for 6+ days

[Source](https://pubmed.ncbi.nlm.nih.gov/16352683/)

Human (Phase I)

GH-deficient adults

Dose-dependent increase in IGF-1 with weekly dosing

[Source](https://pubmed.ncbi.nlm.nih.gov/16352683/)

## Commonly Discussed Benefits

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)[Anti-Aging](/benefits/anti-aging)

Researching CJC-1295 ? Track it, set reminders, and keep notes in the free app.

[Track in App](https://app.peptrackerpro.com/?add=cjc-1295)

## Safety & Cautions

-   May affect blood sugar levels
-   Potential for water retention reported in studies
-   Not FDA-approved for any indication
-   Should be discussed with a healthcare provider

## Comparisons

See how CJC-1295 compares to related peptides:

[CJC-1295 vs AOD-9604](/compare/cjc-1295-vs-aod-9604) [CJC-1295 vs CJC-1295 (DAC)](/compare/cjc-1295-vs-cjc-1295-dac) [CJC-1295 vs DSIP](/compare/cjc-1295-vs-dsip) [CJC-1295 vs Ipamorelin](/compare/cjc-1295-vs-ipamorelin) [CJC-1295 vs Sermorelin](/compare/cjc-1295-vs-sermorelin) [CJC-1295 vs Tesamorelin](/compare/cjc-1295-vs-tesamorelin)

## Calculator Tools

Use our research tools to explore dosing and reconstitution data:

[Reconstitution Calculator](/calculators)

## Citations

1.  \[1\]  Teichman SL. et al. — Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. JCEM. 2006 [PubMed](https://pubmed.ncbi.nlm.nih.gov/16352683/)

### Keep researching in the app

-   Log CJC-1295 to your private tracker 
-   Set a dosing reminder 
-   Compare it side-by-side with your stack 

[Open PepTracker Pro Free](https://app.peptrackerpro.com/?add=cjc-1295) [Browse more peptides](/peptides)

## Related Peptides

### AOD-9604

Medium Evidence 

A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects.

[Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Joint Health](/benefits/joint-health)

[View Details](/peptides/aod-9604) [\+ Compare](/compare?select=aod-9604)[](https://app.peptrackerpro.com/?add=aod-9604)

### CJC-1295 (DAC)

Medium Evidence 

A long-acting GHRH analog with an extended half-life due to its Drug Affinity Complex modification.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)+1 more 

[View Details](/peptides/cjc-1295-dac) [\+ Compare](/compare?select=cjc-1295-dac)[](https://app.peptrackerpro.com/?add=cjc-1295-dac)

### DSIP

Low Evidence 

A neuropeptide studied for its role in sleep regulation and stress modulation.

[Sleep](/benefits/sleep)[Mood](/benefits/mood)[Anxiety Relief](/benefits/anxiety-relief)[Pain Relief](/benefits/pain-relief)

[View Details](/peptides/dsip) [\+ Compare](/compare?select=dsip)[](https://app.peptrackerpro.com/?add=dsip)

### Ipamorelin

Medium Evidence 

A selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Recovery](/benefits/recovery)[Sleep](/benefits/sleep)+1 more 

[View Details](/peptides/ipamorelin) [\+ Compare](/compare?select=ipamorelin)[](https://app.peptrackerpro.com/?add=ipamorelin)

### Sermorelin

Medium Evidence 

A GHRH analog previously FDA-approved for growth hormone deficiency diagnosis and treatment.

[Muscle Growth](/benefits/muscle-growth)[Fat Loss](/benefits/fat-loss)[Sleep](/benefits/sleep)[Recovery](/benefits/recovery)+1 more 

[View Details](/peptides/sermorelin) [\+ Compare](/compare?select=sermorelin)[](https://app.peptrackerpro.com/?add=sermorelin)

### Tesamorelin

High Evidence 

A GHRH analog FDA-approved for reducing visceral fat in HIV-associated lipodystrophy.

[Fat Loss](/benefits/fat-loss)[Muscle Growth](/benefits/muscle-growth)[Metabolism](/benefits/metabolism)[Anti-Aging](/benefits/anti-aging)

[View Details](/peptides/tesamorelin) [\+ Compare](/compare?select=tesamorelin)[](https://app.peptrackerpro.com/?add=tesamorelin)

[PepTracker Pro](/)

Educational peptide information and research tracking tools. Not medical advice.

#### Explore

-   [Peptide Directory](/peptides)
-   [Compare Peptides](/compare)
-   [Glossary](/glossary)
-   [Benefits](/benefits/sleep)

#### Learn

-   [Blog](/blog)
-   [Calculators](/calculators)
-   [Start Here](/start)
-   [About](/about)

#### Legal

-   [Editorial Policy](/editorial-policy)
-   [Research Disclaimer](/research-disclaimer)
-   [Disclaimer](/disclaimer)
-   [Privacy Policy](/privacy)
-   [Terms of Service](/terms)
-   [Contact](/contact)

© 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.